Current Status
Not Enrolled
Get Started

Course: Omega-3 and Concussion

While extensive human studies are lacking and the understanding of underlying mechanisms is still unfolding, multiple studies have shown that the omega-3s EPA and DHA reduce cellular injury and adverse outcomes associated with concussion. Ensuring that omega-3 levels are adequate could play a significant role in protecting the brain and improving functional outcomes in those who are susceptible to repeated head injury in sports like football, soccer and hockey.


Course Overview:

  • Why and how omega-3s are protective of people susceptible to concussion
  • What the latest research shows for ideal blood levels of omega-3s in athletes
  • Why you should test omega-3 levels in patients who train at very high levels and/or play sports where concussion is a major risk factor
  • How to use testing to establish omega-3 dosing for your patients
  • How often to test omega-3 status in your patients


Course Leader:

Kelly Patterson, MS, RD, LDN, CSSD, Clinical Nutrition Educator, OmegaQuant

Kelly Patterson is a Registered Dietitian and Certified Specialist in Sports Dietetics based in Raleigh, NC, and specializing in biomarkers for human performance and longevity. After spending most of her career working for the U.S. Military, including five years as a Tactical Performance Dietitian for Army Special Operations, she is currently the Clinical Nutrition Educator for OmegaQuant Analytics. Kelly completed her bachelor’s degree and dietetic internship at SUNY Buffalo State College in Buffalo, NY, and her master’s degree in human performance and sports nutrition at Logan University in Chesterfield, MO.


These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.